瑞芬太尼静脉自控模式在不同产程分娩镇痛的效果观察

蔡孟; 俞瑾; 陈洪艳; 雷晓峰

doi:10.16016/j.2097-0927.202203149

您当前的位置：

首页 >

文章列表页 >

瑞芬太尼静脉自控模式在不同产程分娩镇痛的效果观察

临床医学 | 更新时间：2026-01-09

- 瑞芬太尼静脉自控模式在不同产程分娩镇痛的效果观察
- Analgesic effectiveness of remifentanil intravenous patient-controlled regimen in different stages of labor analgesia
- 陆军军医大学学报 2022年44卷第17期页码：1785-1790
- 作者机构：
  
  400117 重庆，重庆医科大学附属妇女儿童医院
- 作者简介：
  
  [雷晓峰，E-mail：3495926509@qq.comLEI Xiaofeng, E-mail: 3495926509@qq.com
- 基金信息：
  
  重庆市卫生健康委妇幼科研培育项目(2021FY106)
- DOI：10.16016/j.2097-0927.202203149
  中图分类号： R614.24;R714.3;R971.2
- 收稿：2022-03-17，
  
  修回：2022-04-24，
  
  纸质出版：2022-09-15
- 稿件说明：
移动端阅览
蔡孟, 俞瑾, 陈洪艳, 等. 瑞芬太尼静脉自控模式在不同产程分娩镇痛的效果观察[J]. 陆军军医大学学报, 2022,44(17):1785-1790.

Meng CAI, Jin YU, Hongyan CHEN, et al. Analgesic effectiveness of remifentanil intravenous patient-controlled regimen in different stages of labor analgesia[J]. Journal of Army Medical University, 2022, 44(17): 1785-1790.
蔡孟, 俞瑾, 陈洪艳, 等. 瑞芬太尼静脉自控模式在不同产程分娩镇痛的效果观察[J]. 陆军军医大学学报, 2022,44(17):1785-1790. DOI： 10.16016/j.2097-0927.202203149.

Meng CAI, Jin YU, Hongyan CHEN, et al. Analgesic effectiveness of remifentanil intravenous patient-controlled regimen in different stages of labor analgesia[J]. Journal of Army Medical University, 2022, 44(17): 1785-1790. DOI： 10.16016/j.2097-0927.202203149.

摘要

目的

本研究旨在探讨瑞芬太尼静脉自控镇痛(patient controlled intravenous analgesia

PCIA)方案在第一产程潜伏期、活跃期的有效性、安全性及对血浆前列腺素E2(PGE2)浓度的影响。

方法

选取2021年1月至2022年2月，单胎足月产妇60例，依据产妇自愿原则分为瑞芬太尼静脉分娩镇痛组(R组)和无镇痛组(C组)，每组30例。R组在第一产程潜伏期瑞芬太尼背景剂量0.03 μg/(kg·min)，单次按压剂量0.3 μg/kg，锁定时间2 min；第一产程活跃期：瑞芬太尼背景剂量0.05 μg/(kg·min)，单次按压剂量0.4 μg/kg，锁定时间2 min。记录两组产妇疼痛、镇静、满意度评分；产妇及胎儿不良反应；新生儿Apgar评分和脐动脉血气分析值；R组镇痛前后血浆PGE2浓度值。

结果

与C组比较，R组潜伏期、活跃期平均疼痛评分和最低疼痛评分均显著降低(

0.05)。R组镇静评分、满意度评分高于C组(

0.05)。R组头晕、困倦发生率较高(

0.05)。两组新生儿脐动脉血气分析及Apgar评分差异无统计学意义(

0.05)。R组镇痛前、后血浆中PGE2浓度差异无统计学意义(

0.05)。

结论

根据产程潜伏期和活跃期不同产痛强度，适当调整瑞芬太尼PICA模式，可以明显缓解产妇的分娩痛，对母婴无明显不良反应，对产妇PGE2浓度无影响。

Abstract

Objective

To investigate the effectiveness and safety of intravenous remifentanil patient-controlled intravenous analgesia (PCIA) regimen during the active and latency period of the first labor and its influence on plasma prostaglandin E2 (PGE2) in parturients.

Methods

A total of 60 full-term parturients with a single fetus giving birth vaginally in our center from January 2021 to February 2022 were enrolled in this study. The patients who were willing to receive remifentanil intravenous controlled analgesia formed group R (

=30)

and those who refused analgesia formed group C (

=30). Group R received PCA of remifentanil (continuous background infusion of 0.03 μg/kg·min and bolus doses of 0.3 μg/kg with 2 min lockout period in latent phase; contin

uous background infusion of 0.05 μg/kg·min and bolus doses of 0.4 μg/kg with 2 min lockout period in active phase). Maternal pain score

sedation efficacy

satisfaction

and maternal and fetal adverse reactions were recorded. Neonatal Apgar score and the results of umbilical arterial blood gas analysis were recorded. The levels of PGE2 in R group were determined before and after analgesia.

Results

Compared to Group C

the mean NRS pain score and the lowest pain score of Group R in latent and active phases were significantly lower (

0.05). The overall sedation score and satisfaction score of Group R were obviously higher when compared with Group C (

0.05). The incidences of dizziness and drowsiness were statistically higher in the Group R (

0.05). No differences were seen in the neonatal Apgar score and the results of umbilical arterial blood gas analysis between the 2 groups (

0.05). The serum PGE2 levels had no obvious change in Group R before and after analgesia (

0.05).

Conclusion

According to the different intensities of labor pain in latent and active phase

appropriate adjustment of remifentanil intravenous controlled analgesia regimen can obviously mitigate maternal labor pain

without obvious maternal and fetal adverse reactions

and has no influence on maternal PGE2 levels.

关键词

Keywords

references

ZHANG P J, YU Z Q, ZHAI M L, et al . Effect and safety of remifentanil patient-controlled analgesia compared with epidural analgesia in labor: an updated meta-analysis of randomized controlled trials[J ] . Gynecol Obstet Invest, 2021, 86(3): 231-238. DOI: 10.1159/000515531.

NANJI J A, CARVALHO B. Pain management during labor and vaginal birth[J]. Best Pract Res Clin Obstet Gynaecol, 2020, 67: 100-112. DOI: 10.1016/j.bpobgyn.2020.03.002.

American College of Obstetricians And Gynecologists' Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin no. 209: obstetric analgesia and anesthesia[J]. Obstet Gynecol, 2019, 133(3): e208-e225. DOI: 10.1097/AOG.0000000000003132.

VAN DE VELDE M, CARVALHO B. Remifentanil for labor analgesia: an evidence-based narrative review[J]. Int J Obstet Anesth, 2016, 25: 66-74. DOI: 10.1016/j.ijoa.2015.12.004.

LU G L, YAO W S, CHEN X F, et al . Remifentanil patient-controlled versus epidural analgesia on intrapartum maternal fever: a systematic review and meta-analysis[J ] . BMC Pregnancy Childbirth, 2020, 20(1): 151. DOI: 10.1186/s12884-020-2800-y.

BALKI M, KASODEKAR S, MBBS S D, et al . Remifentanil patient-controlled analgesia for labour: optimizing drug delivery regimens[J ] . Can J Anaesth, 2007, 54(8): 626-633. DOI: 10.1007/BF03022956.

WILSON M J A, MACARTHUR C, HEWITT C A, et al . Intravenous remifentanil patient-controlled analgesia versus intra muscular pethidine for pain relief in labour(RESPITE): an open-label, multicentre, randomised controlled trial[J ] . Lancet, 2018, 392(10148): 662-672. DOI: 10.1016/S0140-6736(18)31613-1.

KRANKE P, GIRARD T, LAVAND'HOMME P, et al . Must we press on until a young mother dies? Remifentanil patient controlled analgesia in labour may not be suited as a "poor man's epidural"[J ] . BMC Pregnancy Childbirth, 2013, 13: 139. DOI: 10.1186/1471-2393-13-139.

HUTCHISON J, MAHDY H, HUTCHISON J. Stages of Labor. 2021 Aug 25. In: StatPearls[Internet]. Treasure Island(FL): StatPearls Publishing; 2022 Jan-. PMID: 31335010.

万丽, 赵晴, 陈军, 等. 疼痛评估量表应用的中国专家共识(2020版)[J]. 中华疼痛学杂志, 2020(3): 177-187.

WAN L, ZHAO Q, CHEN J, et al . Expert consensus on the application of pain evaluation questionnaires in China(2020)[J ] . Chin J Painology, 2020(3): 177-187.

RASHEED A M, AMIRAH M F, ABDALLAH M, et al . Ramsay sedation scale and Richmond agitation sedation scale: a cross-sectional study[J ] . Dimens Crit Care Nurs, 2019, 38(2): 90-95. DOI: 10.1097/DCC.0000000000000346.

CNATTINGIUS S, NORMAN M, GRANATH F, et al . Apgar score components at 5 minutes: risks and prediction of neonatal mortality[J ] . Paediatr Perinat Epidemiol, 2017, 31(4): 328-337. DOI: 10.1111/ppe.12360.

MACONES G A, HANKINS G D V, SPONG C Y, et al . The 2008 National Institute of Child Health and Human Development workshop report on electronic fetal monitoring: update on definitions, interpretation, and research guidelines[J ] . Obstet Gynecol, 2008, 112(3): 661-666. DOI: 10.1097/AOG.0b013e3181841395.

WEIBEL S, JELTING Y, AFSHARI A, et al . Patient-controlled analgesia with remifentanil versus alternative parenteral methods for pain management in labour. Cochrane Database Syst Rev. 2017 Apr 13;4(4): CD011989. DOI: 10.1002/14651858.

李巨. 产科理论与手术[M]. 沈阳: 辽宁科学技术出版社, 1998: 301-2.

LI J. Obstetric Theory and Surgery[M]. Shenyang: Liaoning Science and Technology Press, 1998: 301-2.

DEVABHAKTHUNI S. Efficacy and safety of remifentanil as an alternative labor analgesic[J]. Clin Med Insights Womens Health, 2013, 6: 37-49. DOI: 10.4137/CMWH.S8015.

SHEN M K, WU Z F, ZHU A B, et al . Remifentanil for labour analgesia: a double-blinded, randomised controlled trial of maternal and neonatal effects of patient-controlled analgesia versus continuous infusion[J ] . Anaesthesia, 2013, 68(3): 236-244. DOI: 10.1111/anae.12098.

TVEIT T O, HALVORSEN A, SEILER S, et al . Efficacy and side effects of intravenous remifentanil patient-controlled analgesia used in a stepwise approach for labour: an observational study[J ] . Int J Obstet Anesth, 2013, 22(1): 19-25. DOI: 10.1016/j.ijoa.2012.09.003.

MORAN V H, THOMSON G, COOK J, et al . Qualitative exploration of women's experiences of intramuscular pethidine or remifentanil patient-controlled analgesia for labour pain[J ] . BMJ Open, 2019, 9(12): e032203. DOI: 10.1136/bmjopen-2019-032203.

VOLMANEN P, AKURAL E I, RAUDASKOSKI T, et al . Remifentanil in obstetric analgesia: a dose-finding study[J ] . Anesth Analg, 2002, 94(4): 913-917, tableofcontents. DOI: 10.1097/00000539-200204000-00026.

王淼, 段满林, 刘清仁, 等. 瑞芬太尼用于静脉分娩镇痛的半数有效剂量分析. 实用临床医药杂志. 2017. 21(11): 170-174. DOI: 10.7619/jcmp.201711059.

WANG M, DUAN M L, LIU Q R, et al . Analysis of half e ffective dose of remifentanil for intravenous laboranalgesia. J Prac Clin Med, 2017. 21(11): 170-174. DOI: 10.7619/jcmp.201711059.

OHASHI Y, BAGHIRZADA L, SUMIKURA H, et al . Remifentanil for labor analgesia: a comprehensive review[J ] . J Anesth, 2016, 30(6): 1020-1030. DOI: 10.1007/s00540-016-2233-y.

朱爱兵, 沈明坤, 安舟引, 等. 瑞芬太尼静脉自控镇痛与腰-硬联合镇痛用于分娩镇痛的比较[J]. 临床麻醉学杂志, 2018, 34(9): 853-856.

ZHU A B, SHEN M K, AN Z Y, et al . Comparison of PCIA remifentanil in combined with spinal-epidural analgesia for labor analgesia[J ] . J Clin Anesthesiol, 2018, 34(9): 853-856.

D'ONOFRIO P, NOVELLI A M M, MECACCI F, et al . The efficacy and safety of continuous intravenous administration of remifentanil for birth pain relief: an open study of 205 parturients[J ] . Anesth Analg, 2009, 109(6): 1922-1924. DOI: 10.1213/ane.0b013e3181acc6fc.

STOCKI D, MATOT I, EINAV S, et al . A randomized controlled trial of the efficacy and respiratory effects of patient-controlled intravenous remifentanil analgesia and patient-controlled epidural analgesia in laboring women[J ] . Anesth Analg, 2014, 118(3): 589-597. DOI: 10.1213/ane.0b013e3182a7cd1b.

倪欢欢, 何亮, 陈惠裕. 瑞芬太尼分娩镇痛对产妇及胎儿的影响[J]. 临床麻醉学杂志, 2011, 27(7): 2. DOI: 10.1631/jzus.B1000185.

NI H H, HE L, CHEN H Y. Effect of remifentanil on labor analgesia of puerpera and fetus[J]. J Clin Anesthesiol, 2011, 27(7): 2. DOI: 10.1631/jzus.B1000185

CHENG H, HUANG H Y, GUO Z K, et al . Role of prostaglandin E2 in tissue repair and regeneration[J ] . Theranostics, 2021, 11(18): 8836-8854. DOI:10.7150/thno.63396.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

超声引导下阴部神经阻滞在分娩镇痛及会阴保护中的临床效果观察